Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Budesonide Prophylaxis Reduces Engraftment Syndrome (ES) after Autologous Hematopoietic Cell Transplantation (autoHCT) in Multiple Myeloma (MM)

Bicky Thapa, MD, Huaying Dong, MS, Sergey Tarima, PhD, Binod Dhakal, MS

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-138708

Published: 2020

Journal Articles

Easy-to-Read Informed Consent (ETRIC) Form for Hematopoietic Cell Transplantation (HCT) Clinical Trials: Results from Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1205 Study

Navneet S. Majhail, MD MS, Sergey Tarima, PhD, Ellen Denzen, MS, Heather Moore, MPH, Sunil Abhyankar, MD, Peter Dawson, PhD, Amy Foley, Iris D. Gersten, MS, Mitchell E. Horwitz, MD, Lensa Idossa, MPH, Steven Joffe, MDMPH, Naynesh Kamani, MD, Roberta King, MPH, Aleksandr Lazaryan, MD PhD MPH, Lawrence E Morris, MD, Mary M. Horowitz, MD MS, Ryan Spellecy, PhD

Blood (2017) 130 (Supplement 1): 4687.

https://doi.org/10.1182/blood.V130.Suppl_1.4687.4687

Published: 2017

Journal Articles

Early Mortality in Patients with Acute Promyelocytic Leukemia (APL) Treated in Teaching Versus Non-Teaching Hospitals

Adam Levin, MD, Ariel Kleman, MD, Lisa Rein, MS, Sergey Tarima, PhD, Laura C Michaelis, MD, Karen-Sue B. Carlson, MD PhD, Mehdi Hamadani, MD, Timothy S. Fenske, MD, Parameswaran Hari, MBBS, MD MRCP, Ehab Atallah, MD, Binod Dhakal, MD MS

Blood (2016) 128 (22): 2784.

https://doi.org/10.1182/blood.V128.22.2784.2784

Published: 2016

Journal Articles

Risk Factors and Outcome after Second HLA-Matched Sibling Donor Transplantation for Graft Failure after a First HLA-Matched Sibling Transplant in Severe Aplastic Anemia.

John Horan, MD, Jeanette Carreras, MPH, Sergey Tarima, PhD, Bruce Camitta, MD, Robert Peter Gale, MD, PhD, Wolfgang Hintergerger, MD, Judith Marsh, MD, Ricardo Pasquini, MD, Marcelo Pasquini, MD, MS, Mark Walters, MD, Mary Eapen, MD, MS

Blood (2007) 110 (11): 1110.

https://doi.org/10.1182/blood.V110.11.1110.1110

Published: 2007

Journal Articles

Allogeneic Stem Cell Transplantation (AlloSCT) for the Treatment of Therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML): Results from the Center for International Blood and Marrow Transplant Research (CIBMTR).

Mark Litzow, MD, Waleska S. Pérez, MPH, Sergey Tarima, PhD, Armand Keating, MD, Jorge Sierra, MD, Martin Tallman, MD, Daniel Weisdorf, MD

Blood (2007) 110 (11): 3057.

https://doi.org/10.1182/blood.V110.11.3057.3057

Published: 2007

Journal Articles

Rapid Transport and Infusion of Hematopoietic Stem Cells Can Improve Outcome after Unrelated Donor Transplant.

Hillard M. Lazarus, MD, Fangyu Kan, MS, Sergey Tarima, PhD, Richard E. Champlin, MD, Dennis Confer, MD, Noelle Frey, MD, Sergio Giralt, MD, John E. Wagner, MD, Mary M. Horowitz, MD, Mary Eapen, MBBS

Blood (2007) 110 (11): 3063.

https://doi.org/10.1182/blood.V110.11.3063.3063

Published: 2007

NARROW

Budesonide Prophylaxis Reduces Engraftment Syndrome (ES) after Autologous Hematopoietic Cell Transplantation (autoHCT) in Multiple Myeloma (MM)

Easy-to-Read Informed Consent (ETRIC) Form for Hematopoietic Cell Transplantation (HCT) Clinical Trials: Results from Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1205 Study

Early Mortality in Patients with Acute Promyelocytic Leukemia (APL) Treated in Teaching Versus Non-Teaching Hospitals

Risk Factors and Outcome after Second HLA-Matched Sibling Donor Transplantation for Graft Failure after a First HLA-Matched Sibling Transplant in Severe Aplastic Anemia.

Allogeneic Stem Cell Transplantation (AlloSCT) for the Treatment of Therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML): Results from the Center for International Blood and Marrow Transplant Research (CIBMTR).

Rapid Transport and Infusion of Hematopoietic Stem Cells Can Improve Outcome after Unrelated Donor Transplant.

Email alerts

ASH Publications

American Society of Hematology

Budesonide Prophylaxis Reduces Engraftment Syndrome (ES) after Autologous Hematopoietic Cell Transplantation (autoHCT) in Multiple Myeloma (MM)

Easy-to-Read Informed Consent (ETRIC) Form for Hematopoietic Cell Transplantation (HCT) Clinical Trials: Results from Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1205 Study

Early Mortality in Patients with Acute Promyelocytic Leukemia (APL) Treated in Teaching Versus Non-Teaching Hospitals

Risk Factors and Outcome after Second HLA-Matched Sibling Donor Transplantation for Graft Failure after a First HLA-Matched Sibling Transplant in Severe Aplastic Anemia.

Allogeneic Stem Cell Transplantation (AlloSCT) for the Treatment of Therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML): Results from the Center for International Blood and Marrow Transplant Research (CIBMTR).

Rapid Transport and Infusion of Hematopoietic Stem Cells Can Improve Outcome after Unrelated Donor Transplant.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only